Id |
Description |
Lang |
Type |
Status |
Case? |
Module |
1202500013 |
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet (product) |
en |
Fully specified name |
Active |
Entire term case insensitive (core metadata concept) |
SNOMED CT core |
1478560013 |
Amylase+lipase, pancreatic+protease, pancreatic 12500unt/1000unt/12500unt tablet |
en |
Synonym (core metadata concept) |
Active |
Entire term case insensitive (core metadata concept) |
SNOMED CT core |
1202500013 |
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet (product) |
en |
Fully specified name |
Active |
Only initial character case insensitive (core metadata concept) |
SNOMED CT core |
1202500013 |
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet (product) |
en |
Fully specified name |
Active |
Entire term case insensitive (core metadata concept) |
SNOMED CT core |
1215411017 |
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet |
en |
Synonym (core metadata concept) |
Active |
Only initial character case insensitive (core metadata concept) |
SNOMED CT core |
1478560013 |
Amylase+lipase, pancreatic+protease, pancreatic 12500unt/1000unt/12500unt tablet |
en |
Synonym (core metadata concept) |
Active |
Only initial character case insensitive (core metadata concept) |
SNOMED CT core |
1478560013 |
Amylase+lipase, pancreatic+protease, pancreatic 12500unt/1000unt/12500unt tablet |
en |
Synonym (core metadata concept) |
Active |
Entire term case insensitive (core metadata concept) |
SNOMED CT core |
Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet |
Is a |
Amylase-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Amylase (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
A substance containing enzymes, mainly lipase, with amylase and protease, obtained from the pancreas of the hog. It is a cream-coloured, amorphous powder having a faint characteristic, but not offensive odour. Its greatest activities are in neutral or faintly alkaline media; more than traces of mineral acids or large amounts of alkali hydroxides make it inert. An excess of alkali carbonate also inhibits its action. Pancrelipase contains, in each mg, not less than 24 USP units of lipase activity, not less than 100 USP units of amylase activity, and not less than 100 USP units of protease activity. |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet |
Is a |
Product containing amylase and substance with protease mechanism of action and triacylglycerol lipase |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
proteasi |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Lipase |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet |
Has manufactured dose form |
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Triacylglycerol lipase (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet |
Has manufactured dose form |
Conventional release oral tablet (dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Endopeptidase |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet |
Is a |
Product manufactured as oral dose form (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|